- Home
- ITOS vs CUB Comparison
ITOS vs CUB Comparison
Compare ITOS & CUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- CUB
- Stock Information
- Founded
- ITOS 2011
- CUB 2024
- Country
- ITOS United States
- CUB United States
- Employees
- ITOS N/A
- CUB N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- CUB
- Sector
- ITOS Health Care
- CUB
- Exchange
- ITOS Nasdaq
- CUB NYSE
- Market Cap
- ITOS 323.2M
- CUB 307.3M
- IPO Year
- ITOS 2020
- CUB 2024
- Fundamental
- Price
- ITOS $9.17
- CUB $10.03
- Analyst Decision
- ITOS Strong Buy
- CUB
- Analyst Count
- ITOS 4
- CUB 0
- Target Price
- ITOS $32.50
- CUB N/A
- AVG Volume (30 Days)
- ITOS 692.7K
- CUB 33.4K
- Earning Date
- ITOS 11-15-2024
- CUB 01-01-0001
- Dividend Yield
- ITOS N/A
- CUB N/A
- EPS Growth
- ITOS N/A
- CUB N/A
- EPS
- ITOS N/A
- CUB N/A
- Revenue
- ITOS $35,000,000.00
- CUB N/A
- Revenue This Year
- ITOS $271.18
- CUB N/A
- Revenue Next Year
- ITOS N/A
- CUB N/A
- P/E Ratio
- ITOS N/A
- CUB N/A
- Revenue Growth
- ITOS N/A
- CUB N/A
- 52 Week Low
- ITOS $8.41
- CUB $9.96
- 52 Week High
- ITOS $18.75
- CUB $10.49
- Technical
- Relative Strength Index (RSI)
- ITOS 46.37
- CUB N/A
- Support Level
- ITOS $8.41
- CUB N/A
- Resistance Level
- ITOS $9.14
- CUB N/A
- Average True Range (ATR)
- ITOS 0.49
- CUB 0.00
- MACD
- ITOS 0.21
- CUB 0.00
- Stochastic Oscillator
- ITOS 71.58
- CUB 0.00
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About CUB LIONHEART HOLDINGS
Lionheart Holdings is a blank check company.